Social Media Ideas for Galderma

Is Galderma a good company to work for?

Is Galderma a good company to work for? Anonymous (not verified) Thu, 08/20/2026 - 06:37 field_thread_url https://cafepharma.com/boards/threads/is-galderma...

Galderma Group AG 2026 Q2 - Results - Earnings Call Presentation

Galderma Opens New Headquarters in Miami to Support US and Latin American Operations

The facility features a dedicated training space for healthcare professionals and supports the company’s long-term investment in the dermatology market.

Derm

Derm Anonymous (not verified) Sun, 07/26/2026 - 18:23 field_thread_url https://cafepharma.com/boards/threads/derm.714954/ board name...

Derm

Derm Anonymous (not verified) Tue, 08/18/2026 - 03:36 field_thread_url https://cafepharma.com/boards/threads/derm.690595/ board name...

Dermatology launch

Dermatology launch Anonymous (not verified) Thu, 07/16/2026 - 12:16 field_thread_url https://cafepharma.com/boards/threads/dermatology-launch.716833/...

Derm

Derm Anonymous (not verified) Fri, 07/24/2026 - 18:22 field_thread_url https://cafepharma.com/boards/threads/derm.714954/ board name...

<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...

Leo Pharma buys rare skin disease drug in $435M deal

Tanabe Pharma has already asked the FDA to approve the medicine for two conditions that cause severe reactions to sunlight.

กัลเดอร์มา ตอกย้ำ 30 ปีแห่งนวัตกรรม “รายแรกของโลก” พร้อมเปิดสำนักงานใหม่ใจกลางกรุงเทพฯ

กัลเดอร์มา คือหนึ่งในไม่กี่องค์กรที่เป็นผู้บุกเบิกนวัตกรรมด้านความงามในหลากหลายกลุ่มผลิตภัณฑ์ ตั้งแต่การเปิดตัวผลิตภัณฑ์สารเติมเต็มไฮยาลูโรนิก แอซิด ที่ใช้ SB-NASHA™ เป็นรายแรกในปี...

Laboratoires Pierre Fabre appoints Zombré CEO of U.S. Dermocosmetics operations in Secaucus

Laboratoires Pierre Fabre, the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical groups, announced Aug. 25 the appointment of Nicolas Zombré...

Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

- A new chapter in skincare has arrived -- This will be Dermata's first commercial product launch, planned for August 25, 2026 -- Join the waitlist at tomeskincare.com -

<![CDATA[argenx Acquires Forte Biosciences for $2.2 Billion]]>

Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill

Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde. 

Just got derm offer

Just got derm offer Anonymous (not verified) Fri, 08/07/2026 - 00:29 field_thread_url https://cafepharma.com/boards/threads/just-got-derm-offer.717502/...

Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nod

Leo Pharma is sticking to its mission of strengthening its pipeline in 2026, penning a $435 million deal for a rare skin disease drug from Tanabe Pharma that's awaiting an approval...

Just got derm offer

Just got derm offer Anonymous (not verified) Tue, 08/04/2026 - 21:28 field_thread_url https://cafepharma.com/boards/threads/just-got-derm-offer.717502/...

Sanofi halts development of troubled immune drug in eczema

The decision to no longer seek approval of amlitelimab is the latest setback for a treatment once hailed as a future blockbuster. One analyst expects Sanofi to now pursue “strategi...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award

A New York federal court confirmed an arbitrator's finding that Sun Pharmaceuticals breached an agreement with the owner of an acne drug by seeking regulatory approval to market a...

Any offers out for Derm?

Any offers out for Derm? Anonymous (not verified) Mon, 08/10/2026 - 00:31 field_thread_url https://cafepharma.com/boards/threads/any-offers-out-for-derm.71...

Chasing Dupixent, a biotech aims to make better antibody drugs for eczema

Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.

EU Approves Galderma’s Bone-Mimicking Injectable for Chin Augmentation

The hyaluronic acid gel is designed to mimic bone for lower face shaping and uses a new technology to provide firmness.

Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout

Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once tipped as a potential blockbuster “would not represent a meaningful imp...